Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for DABUR.BO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DABUR.BO and 80,000+ other tickers.
See exactly how DABUR.BO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DABUR.BO and 80,000+ other tickers.
Dabur India Limited operates as a globally recognized fast-moving consumer goods (FMCG) enterprise. Its diverse business model encompasses Consumer Care, Foods, Retail, and other segments. The company provides a wide array of health supplements, including well-known brands such as Dabur Chyawanprash, Dabur Vita, Dabur Honey, Dabur Immunity Kit, Dabur Vedic Suraksha Tea, and Dabur Glucose. For digestive wellness, its offerings feature Dabur Hajmola, Pudin Hara, Hingoli, Dabur Nature Care, and Sat Isabgol. In personal care, Dabur manufactures shampoos like Dabur Almond and Vatika, alongside a…
No recent news available.